Patent 6872852 was granted and assigned to MediQuest Therapeutics on March, 2005 by the United States Patent and Trademark Office.
Cytotoxic polyamine analogues are provided that are useful for treating diseases where it is desired to inhibit cell growth and/or proliferation, for example cancer and post-angioplasty injury.